"If you or a loved one is suffering from kidney disease and related conditions, Columbia Nephrology can help. As The Midlands area’s largest nephrology practice, it’s the place to come for comprehensive, convenient treatment plans delivered by specialists. Innovative technology and an active research team ensure patients receive the highest quality care possible — and in the shortest amount of time. Our compassionate staff understands your desire to get back to an energized life free from pain and discomfort, and we work to ensure minimal wait times so patients can get in and out of treatments as quickly as possible."

During the past decade, Columbia Nephrology Associates, PA conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Columbia Nephrology Associates, PA" #1 sponsor was "Pfizer" with 4 trials, followed by "Reata Pharmaceuticals, Inc." with 3 trials sponsored, "Ardelyx" with 1 trials sponsored, "Christopher Granger, MD" with 1 trials sponsored and "KBP Biosciences" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia Nephrology Associates, PA" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Columbia Nephrology Associates, PA" are "Chronic Kidney Diseases" (4 trials), "Autosomal Dominant Polycystic Kidney" (2 trials), "Chronic Kidney Disease" (2 trials), "Chronic Renal Failure" (2 trials) and "End Stage Renal Disease" (2 trials). Many other conditions were trialed in "Columbia Nephrology Associates, PA" in a lesser frequency.

Most popular intervention types in "Columbia Nephrology Associates, PA" are "Drug" (9 trials), "Biological" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Epoetin Hospira" (3 trials), "Bardoxolone methyl oral capsule" (2 trials), "Placebo oral capsule" (2 trials) and "Bardoxolone methyl" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia Nephrology Associates, PA" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Columbia Nephrology Associates, PA". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Columbia Nephrology Associates, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia Nephrology Associates, PA, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".